TrialPanorama/TrialPanorama-database huggingface dataset:
Study: NCT03628079

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: ReposMBZ
Description: Capsules 50mg, 100mg, 200mg
Study: NCT00507637

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: NT 201
Description: Injection of up to 50 Units NT 201 (incobotulinumtoxinA/Xeomin®) per eye and injection visit (8 injections visits in total).
Study: NCT03255018

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Pembrolizumab
Description: Administered intravenously (IV) at a fixed dose of 200 mg every 3 weeks until disease progression or unacceptable toxicity; treatment may continue indefinitely if clinical benefit with options for treatment interruption if responding disease and re-treatment upon relapse.
Study: NCT06068166

Intervention type: COMBINATION_PRODUCT
Group type: EXPERIMENTAL
Intervention: TEA plus GDMT
Description: Thoracic epidural anesthesia (TEA), the infusion of anesthetic agents (eg, lidocaine or ropivacaine) into the epidural space, is used to achieve sympathetic block at the T1 to T4 levels in thoracic and abdominal surgical procedures. Since 1995, Professor Liu Fengqi has pioneered the use of TEA to treat end-stage HFrEF and achieved surprising results. TEA could reduce the enlarged heart cavity, halt and reverse cardiac remodeling, and improve cardiac systolic and diastolic function. Currently, thousands of HFrEF patients have received TEA procedure. All the patients received maximally tolerated guideline-directed medical therapy (GDMT).

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: GDMT
Description: All the patients received maximally tolerated guideline-directed medical therapy (GDMT) alone.
Study: NCT02699801

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: propofol
Description: propofol for post-sternal closure sedation

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Dexmedetomidine
Description: dexmedetomidine for post-sternal closure sedation
Study: NCT01054430

Intervention type: DRUG
Group type: OTHER
Intervention: avanafil
Description: 200 mg avanafil tablets QD

Intervention type: DRUG
Group type: OTHER
Intervention: avanafil
Description: 200 mg avanafil tablets QD

Intervention type: DRUG
Group type: OTHER
Intervention: avanafil
Description: 200 mg avanafil tablets QD
Study: NCT02606292

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Photoacoustic endoscopy

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Endoscopic ultrasound (standard of care)

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Endoscopic surgery (standard of care)
Study: NCT03767114

Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: RT-PCR for ERAP1 detection
Description: Reverse transcriptase -Polymerase Chain Reaction for ERAP1 detection

Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: RT-PCR for ERAP1 detection
Description: Reverse transcriptase -Polymerase Chain Reaction for ERAP1 detection
Study: NCT02388555

Intervention type: PROCEDURE
Intervention: Posterior osteotomy correction
Description: The DLS patients underwent osteotomy including pedicle subtraction osteotomy (PSO) or Smith-Petersen osteotomy (SPO)
Study: NCT03719677

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Habit development intervention
Description: Lifestyle behavior change intervention targeting physical activity and dietary habit development as well as improving physical and social functioning
Study: NCT03789799

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: TIAB: microcrystalline titanium dioxide with covalently linked monovalent silver ions
Description: TIAGIN vaginal capsule, composition: TIAB (microcrystalline titanium dioxide with covalently linked monovalent silver ions), Sodium Hyaluronate, Aloe Barbadensis Extract

Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Placebo vaginal capsule, composition: Sodium Hyaluronate, Aloe Barbadensis Extract
Study: NCT03074851

Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: low sodium salt
Description: To give free low sodium salt intervention for 2 months

Intervention type: OTHER
Group type: OTHER
Intervention: informational intervention
Description: to give reporter informational intervention.
Study: NCT00017004

Intervention type: RADIATION
Group type: EXPERIMENTAL
Intervention: External Beam Radiation Therapy
Description: Undergo radiation

Intervention type: RADIATION
Group type: EXPERIMENTAL
Intervention: External Beam Radiation Therapy
Description: Undergo radiation
Study: NCT04112316

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Liothyronine
Description: Liothyronine (L-triiodothyronine or LT3) in the 5 mcg tablet dose formulation. Minimum LT3 dose was 2.5 mcg three times daily and the maximum LT3 dose was 12.5 mcg three times daily.

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Liothyronine
Description: Liothyronine (L-triiodothyronine or LT3) in the 5 mcg tablet dose formulation. Minimum LT3 dose was 2.5 mcg three times daily and the maximum LT3 dose was 12.5 mcg three times daily.
Study: NCT00017004

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Cisplatin
Description: Given IV
Study: NCT04112316

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Placebo
Description: A placebo tablet matching in appearance to LT3 tablets. Minimum placebo tablet dose was 1/2 tablet three times daily and the maximum placebo dose was 2 1/2 tablets three times daily.

Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: A placebo tablet matching in appearance to LT3 tablets. Minimum placebo tablet dose was 1/2 tablet three times daily and the maximum placebo dose was 2 1/2 tablets three times daily.
Study: NCT04640857

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Silk'n Toothwave
Description: patients will receive a non-surgical treatment which will include oral hygiene instructions, calculus removal with ultrasonic and manual instruments. At the end of the meeting they will be provided with a toothbrush which is based on a radiofrequency technology.

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Silk'n Toothwave
Description: patients will receive a non-surgical treatment which will include oral hygiene instructions, calculus removal with ultrasonic and manual instruments. At the end of the meeting they will be provided with a toothbrush which is based on a radiofrequency technology.
Study: NCT00017004

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Cisplatin
Description: Given IV

Intervention type: RADIATION
Group type: EXPERIMENTAL
Intervention: Internal Radiation Therapy
Description: Undergo radiation

Intervention type: RADIATION
Group type: EXPERIMENTAL
Intervention: Internal Radiation Therapy
Description: Undergo radiation

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Epoetin Alfa
Description: Given SC
Study: NCT01107626

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Paclitaxel
Description: Given IV

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Paclitaxel
Description: Given IV

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Paclitaxel
Description: Given IV

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Carboplatin
Description: Given IV
Study: NCT04385095

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Placebo via inhalation
Study: NCT05815849

Intervention type: DIETARY_SUPPLEMENT
Group type: ACTIVE_COMPARATOR
Intervention: Olive oil
Description: 0.5 cc/30 ml of olive oil (a brand easily available in the markets) was added to the milk at each feeding of the infants in the intervention group
Study: NCT01107626

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Carboplatin
Description: Given IV

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Carboplatin
Description: Given IV

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Bevacizumab
Description: Given IV
Study: NCT04414137

Intervention type: OTHER
Intervention: Description of eosinophilic pneumonia due to daptomycine
Description: Description of eosinophilic pneumonia in patients treated by daptomycin for an osteoarticular infection
Study: NCT01107626

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Bevacizumab
Description: Given IV

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Bevacizumab
Description: Given IV

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Pemetrexed Disodium Heptahydrate
Description: Given IV

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Pemetrexed Disodium Heptahydrate
Description: Given IV
Study: NCT02923128

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Dexmedetomidine
Description: Dexmedetomidine 3 ug/kg is diluted to 150ml with 0.9% saline,continuous micro-pump infusion for 72 hours with 2ml/h speed.

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Sufentanyl
Description: Sufentanyl 3 ug/kg is diluted to 150ml with 0.9% saline,continuous micro-pump infusion for 72 hours with 2ml/h speed.
Study: NCT04516330

Intervention type: GENETIC
Group type: ACTIVE_COMPARATOR
Intervention: miRNA
Description: miRNA's expressed in breast cancer
Study: NCT02923128

Intervention type: DRUG
Group type: SHAM_COMPARATOR
Intervention: Sufentanyl
Description: Sufentanyl 3 ug/kg is diluted to 150ml with 0.9% saline,continuous micro-pump infusion for 72 hours with 2ml/h speed.

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Saline
Description: Saline is used to dilute other drugs

Intervention type: DRUG
Group type: SHAM_COMPARATOR
Intervention: Saline
Description: Saline is used to dilute other drugs
Study: NCT04499378

Intervention type: DIAGNOSTIC_TEST
Intervention: Lung CT
Description: Computed tomography of the thorax

Intervention type: DIAGNOSTIC_TEST
Intervention: Lung CT
Description: Computed tomography of the thorax
Study: NCT04313010

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: PRF
Description: A sample of whole venous blood was drawn from the patient's forearm. The blood sample was transferred into a tube without anticoagulant and centrifuged immediately using a centrifuge.

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: BC
Description: According to the procedures of regenerative endodontics therapy, BC was made by the way of provoking apical bleeding into root canal.
Study: NCT01996423

Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Vitamin D3
Study: NCT01280591

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Naproxen sodium 440 mg / DPH 50 mg (BAY98-7111)
Description: Participants received two Naproxen sodium 220 mg / DPH (Diphenhydramine hydrochloride) 25 mg tablets orally, single dose
Study: NCT01996423

Intervention type: DIETARY_SUPPLEMENT
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Study: NCT02250924

Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Caffeine
Description: caffeinated gum

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Gum
Description: Chewing gum

Intervention type: OTHER
Group type: SHAM_COMPARATOR
Intervention: Gum
Description: Chewing gum
Study: NCT01280591

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Naproxen sodium 220 mg / DPH 50 mg (BAY98-7111)
Description: Participants received one Naproxen sodium 220 mg / DPH 50 mg tablet and one matching placebo capsule orally, single dose

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Naproxen sodium 440 mg (BAYH6689)
Description: Participants received two Naproxen sodium 220 mg tablets orally, single dose

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: DPH 50 mg
Description: Participants received two DPH (Diphenhydramine hydrochloride) 25mg tablets orally, single dose
Study: NCT03076736

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Singing group + resource pack
Description: SPA is a community-based, 10 weekly singing group. Each SPA session comprises 30 minutes of settling in/wrap-up and departure, and 60 minutes of group singing. Sessions will be led by a community music leader, co-facilitated by a person with aphasia, and involve the group singing from a songbook. Musical accompaniment will be provided by the facilitator(s). Small percussion instruments will be available for participants, enabling involvement of those with limited singing ability. Intervention content integrates the Information-Motivation-Behavioural (IMB) skills model of health behaviour change to support individuals in developing the social skills and confidence needed to improve psychosocial outcomes. Participants will also receive the resource pack.

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Resource pack
Description: Resource pack with information on living with aphasia and local community activities.
Study: NCT01121783

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Lactisole
Description: A pre-infusion of lactisole solution (0.25mg/ml) is administered as a bolus (1ml/kg bodyweight)via intragastric tube. After 15 minutes a 1M glucose solution is administered as a bolus via intragastric tube.

Intervention type: DIETARY_SUPPLEMENT
Group type: ACTIVE_COMPARATOR
Intervention: Lactisole
Description: A pre-infusion of lactisole solution (0.25mg/ml)is administered as a bolus (1ml/kg body weight) via intragastric tube. After 15 minutes tap water will be administered as a bolus via the intragastric tube.

Intervention type: DIETARY_SUPPLEMENT
Group type: PLACEBO_COMPARATOR
Intervention: Lactisole
Description: A pre-infusion of tap water(is administered as a bolus (1ml/kg bodyweight)via intragastric tube. After 15 minutes a 1M glucose solution is administered as a bolus via intragastric tube.

Intervention type: DIETARY_SUPPLEMENT
Group type: PLACEBO_COMPARATOR
Intervention: Lactisole
Description: A pre-infusion of tap water is administered as a bolus (1ml/kg bodyweight)via intragastric tube. After 15 minutes tap water is administered as a bolus via intragastric tube.
Study: NCT02380430

Intervention type: OTHER
Intervention: ambulatory surgery description
Description: Medical questionnaire. Nausea and vomiting, pain, thromboprophylaxis description
Study: NCT02620332

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: MultiPepT1De injection
Description: A mix of peptides

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: MultiPepT1De injection
Description: A mix of peptides

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: MultiPepT1De injection
Description: A mix of peptides

Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Water for injection
Study: NCT02250924

Intervention type: BEHAVIORAL
Group type: PLACEBO_COMPARATOR
Intervention: wear silicone bracelet
Description: Subjects will put on bracelet to correspond with times for chewing gum
Study: NCT02390557

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Survey
Description: PDQS survey reports only

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Survey
Description: PDQS survey reports only
Study: NCT00523289

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Bupivacaine
Description: Dosage: 150mg at once for anesthesia induction

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Ropivacaine
Description: Single dose of ropivacaine, 150mg
Study: NCT02390557

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: YESHealth
Description: Arm 3: YESHealth and PDQS survey reports to providers
Study: NCT03263793

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Choral (group) singing therapy sessions
Description: Choral (group) singing therapy sessions will be conducted once weekly and daily home practice exercises will be assigned. All vocal exercises are based on principles that have been successful in other intensive Parkinson Disease vocal exercise programs.
Study: NCT00768183

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: KADIAN Capsule + alcohol (under fasting conditions)
Description: Capsules 100 mg + 240 mL 40% ethanol in 4 shots of 60 mL

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: KADIAN Capsule + water (under fasting conditions)
Description: Capsules 100mg + 240 mL in 4 shots of 60 mL

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: morphine sulfate IR oral solution + water
Description: Morphine sulfate IR oral solution + water (under fasting conditions)

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: KADIAN Capsule + alcohol (under fed conditions)
Description: Capsules 100 mg + 240 mL 40% ethanol in 4 shots of 60 mL
Study: NCT01540266

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Information structuring
Description: Students were independently shown one of two videos in which the same physician conveyed the identical 28 items of information to an older patient (played by an actor) in either structured or non-structured form

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Information structuring
Description: Students were independently shown one of two videos in which the same physician conveyed the identical 28 items of information to an older patient (played by an actor) in either structured or non-structured form

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Information structuring
Description: Students were independently shown one of two videos in which the same physician conveyed the identical 28 items of information to an older patient (played by an actor) in either structured or non-structured form
Study: NCT02467491

Intervention type: DEVICE
Group type: OTHER
Intervention: Jintronix
Description: The participants will perform light exercises using the Jintronix software. Jintronix is an easy-to-use virtual physical activity platform designed for physical and occupational therapy. It combines common exercise movements, virtual games and motion sensing cameras to offer a fun and effective tool for physical activity.
Study: NCT01711918

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Domperidone
Description: oral tablet; dose is 10mg per tablet given up to 3 times daily.
Study: NCT01540266

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: no information structuring
Description: Students were independently shown one of two videos in which the same physician conveyed the identical 28 items of information to an older patient (played by an actor) in either structured or non-structured form

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: no information structuring
Description: Students were independently shown one of two videos in which the same physician conveyed the identical 28 items of information to an older patient (played by an actor) in either structured or non-structured form
Study: NCT01227642

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: An ultrasound-based technique to identify prostate cancer
Description: The technique uses current ultrasound equipment already in use for prostate brachytherapy guidance.By extracting and processing the radiofrequency signal obtained from the ultrasound transducer in ways not done to create the standard B-mode ultrasound image, areas of cancer can be identified and displayed overlying the standard B-mode ultrasound image. Comparing the results with this technique to the results of prostate biopsies demonstrates a high degree of accuracy with the area under the receiver-operator characteristic curve of 0.87, a result superior to any other imaging methods.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: pre-implant transrectal ultrasound images and planning
Description: an ultrasound-based technique to identify cancer-containing areas within the prostate.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: ultrasound-based cancer-specific images
Description: ultrasound-based cancer-specific images of the prostate prior to the brachytherapy and use them to direct the dosimetry planning
Study: NCT01540266

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: no information structuring
Description: Students were independently shown one of two videos in which the same physician conveyed the identical 28 items of information to an older patient (played by an actor) in either structured or non-structured form
Study: NCT00761631

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: 13 valent pneumococcal conjugate vaccine
Description: Intramuscular injection of 0.5mL at visit 1 and visit 2 for group 1 and and visit 1 for groups 2, 3, and 4.
Study: NCT02935842

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Specific SL-therapy
Description: Provided by a professional speech-language therapist (SLT) on a one-to-one basis. In approx. 45 Minutes sessions, 3 times per week for 4 weeks in total.

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Specific SL-therapy
Description: Provided by a professional speech-language therapist (SLT) on a one-to-one basis. In approx. 45 Minutes sessions, 3 times per week for 4 weeks in total.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Rhythmic Balance-Movement Training (rBMT)
Description: Provided on a one-to-one basis. In approx. 30-45 Minutes sessions, 3 times per week for 4 weeks in total.

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Rhythmic Balance-Movement Training (rBMT)
Description: Provided on a one-to-one basis. In approx. 30-45 Minutes sessions, 3 times per week for 4 weeks in total.
Study: NCT04820517

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Roy Adaptation Model Based Strengthening Program
Description: Applications included in the strengthening program sessions:~* Awareness study on social media addiction and its effects~* Awareness work on the correct and effective use of leisure time~* As a result of social media addiction, within the scope of Roy Adaptation Model, scenario sharing and problem solving process related to the problems arising in the fields of physical, group identity - self, role and interdependence~* Awareness work on recognizing and managing emotions~* Relaxation and Breathing Exercise in Emotion Management
Study: NCT03820271

Intervention type: OTHER
Group type: OTHER
Intervention: SuperMELD
Description: The population of this arm will consist of patients newly enrolled in the National Liver Transplantation Waiting List for decompensated cirrhosis, whose liver function and MELD score are assessed at enrollment and then routinely reassessed at least quarterly during the waiting phase.~Patients will be followed from their listing to transplantation or discharge or death.
Study: NCT05498012

Intervention type: COMBINATION_PRODUCT
Group type: PLACEBO_COMPARATOR
Intervention: placebo dental gel, placebo toothpaste
Description: * Placebo dental gel applied by dentist after oral hygiene; without cannabidiol.~* Placebo toothpaste; without cannabidiol. For daily use by patient.

Intervention type: COMBINATION_PRODUCT
Group type: EXPERIMENTAL
Intervention: Cannabidiol dental gel, Cannabidiol toothpaste
Description: * Cannabidiol dental gel applied by dentist after oral hygiene; containing 1 % (w/w) cannabidiol.~* Cannabidiol toothpaste; containing 1 % (w/w) cannabidiol. For daily use by patient.

Intervention type: COMBINATION_PRODUCT
Group type: ACTIVE_COMPARATOR
Intervention: Placebo toothpaste, Corsodyl dental gel
Description: * Corsodyl dental gel; containing 1 % (w/w) chlorhexidini digluconatis applied by dentist after oral hygiene.~* Placebo toothpaste; without cannabidiol. For daily use by patient.